Ribbon Biolabs, the DNA synthesis company, announced that the U.S. Patent and Trademark Office has issued U.S. Patent US 11352619 B2, covering Ribbon Biolabs’ novel method for synthesising DNA, using a diverse library of oligonucleotides.
Terumo Pharmaceutical Solutions (TPS), a manufacturer of injection, primary container, and infusion therapy devices, has launched a pre-fillable polymer syringe for low dose applications such as ophthalmic drugs.
Impel NeuroPharma, a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, announced that it is changing its name to Impel Pharmaceuticals.
Technology supplier to the life sciences industry Cytiva is opening a new manufacturing facility in Cardiff, Wales as parts of its global expansion plans.
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic.
Life science manufacturing has notoriously high energy consumption, often due to the necessary use of cleanrooms. However, Cillian Casey, head of Operations and Customer Success – EMEA, at CIM argues that the solution lies in HVAC energy reduction.
In this episode of The MedTalk Podcast, EPM editor, Reece Armstrong speaks to Professor Saad Shakir, Director of the Drug Safety Research Unit about the organisation's work to monitor the safety of Covid-19 vaccines after they were approved for use.
Reece Armstrong speaks to Cathal Friel, chairman and co-founder of Open Orphan, about the company's involvement in setting up the first human challenge study model for Covid-19 and the importance of studying the virus during the pandemic.
Ipsen Pharmaceuticals and rare disease digital health specialists, Mendelian, has launched a new partnership to utilise Mendelian’s MendelScan software, a Class 1 Medical Device capable of aiding the rapid identification of people with rare diseases.
